Dr. Henry Brem
is the Harvey Cushing Professor of
Neurosurgery at the Johns Hopkins University, Director of the
Neurosurgery, and Neurosurgeon-in-Chief. He also is a professor of
Ophthalmology, and Biomedical Engineering.
Dr. Brem has
developed techniques that have forever changed
the field of neurosurgery.Dr.
carried out an important clinical study that helped introduce
imaging into the neurosurgical field.
has changed the surgical techniques used
against brain tumors by inventing and developing Gliadel®
intraoperatively deliver chemotherapy to brain tumors.This new drug delivery system has shown that
surgeons can accurately deliver medications directly at the tumor site.
Dr. Henry Brem
has changed the surgical treatment of brain
tumors by introducing new approaches for drug delivery systems and
therapy.One of the
ways that he has
done this is by designing and leading the clinical trials demonstrating
and efficacy of these new drug delivery systems. Brem used his
experience to design and lead many multi-institutional clinical trials
the safety and efficacy of this drug delivery system for patients with
fact, Dr. Berm will be a Plenary speaker at the MIT 14th
Symposium on Drug Delivery Systems Symposiums on the advances
In 2000, Brem
was named director of the Department of
Neurosurgery at Johns Hopkins. Since his appointment, Brem has been
research boundaries to enhance patient’s outcomes in the
field of neurosurgery.
His commitment to patient care is further demonstrated by being a
member of the Armstrong Institute for Patient Safety and Quality.
DeSimone achievements include publishing over two hundred and seventy
scientific articles and holds one hundred and twenty patents with over
one hundred patents pending. He also received over fifty major awards
The 2010 AAAS Mentor Award
The 2009 NIH Director’s Pioneer Award
The 2009 North Carolina Award
The 2008 Lemelson-MIT Prize for Invention and Innovation
In 2002, with Dr. Richard Stack from Duke University and Dr.
Robert Langer from MIT, DeSimone co-founded BVS. BVS stands
for Bioabsorbable Vascular Solutions which is a fully bioabsorbable,
drug-eluting stent. In 2011 this stent received the European CE Mark
approval. It is currently being evaluated further in numerous clinical
DeSimone is one of the few people that has membership in all three U.S.
National Science Academies:
The Institute of Medicine in 2014
The U.S. National Academy of Sciences in 2012
The U.S. National Academy of Engineering in 2005
Joseph DeSimone has spoken on the popular topic of 3D
printing. In his speech he unveiled a new 3D printing
technique that is twenty-five to one hundred times faster. Joseph
DeSimone made breakthrough contributions
in 3D Printing. He co-founded a 3D printing company in
Silicon Valley called Carbon 3D in 2003 and helped create the new CLIP
3D printing system. Though it’s not the only company
he’s founded. He's the co-founder of several companies,
including Micell Technologies, Bioabsorbable Vascular Solutions,
Liquidia Technologies and Carbon3D.